AMR NEWS: Your Global Source for the Latest AMR Insights and Publications!

Search for:

Home » _News » Smart Innovations » Page 6

AMR news related to Smart Innovations

For scientists, researchers, and innovators committed to staying at the forefront of antimicrobial resistance, AMR Insights provides the most comprehensive, up-to-date overview of global news and breakthroughs. Access cutting-edge research, expert insights, and the latest developments to fuel your work and accelerate progress in the fight against AMR.

Translating eco-evolutionary biology into therapy to tackle antibiotic resistance

Facing the Pandemic of Antimicrobial Resistance: Current Actions and Future Challenges in Antibiotic Stewardship, Access, and Innovation in Brazil

New WHO report highlights progress, but also remaining gaps, in ensuring a robust pipeline of antibiotic treatments to combat antimicrobial resistance (AMR)

Government of Canada makes important investment to fight antimicrobial resistance (AMR)

Making antibacterial supermolecules

Vivli AMR Surveillance Open Data Re-use Challenge: express your interest until 30 June

Chan Zuckerberg ID Makes Strides in Enabling Pathogen Identification From Metagenomic Data

Bootcamp: In Vitro Diagnostic Product Development

Inhibitors of ATP Synthase as New Antibacterial Candidates

BARDA Support Protects Against Drug-Resistant Threats

Bennet, Young, Bipartisan House Colleagues reintroduce bipartisan PASTEUR act to fight antimicrobial resistance

CARB-X 2021-22 ANNUAL REPORT LAUNCHED

GARDP Webinar: How can non-profit drug developers counter AMR?

Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance

EC: Reform of the pharmaceutical legislation and measures addressing antimicrobial resistance

EU to test disputed incentive scheme to develop novel antibiotics

The compassionate use of bacteriophages for failed persistent infections during the first five years of the Israeli Phage Therapy Center (IPTC)

Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional study

New global research consortium to optimise antimicrobial use in humans

Diagnostic stewardship in infectious diseases: a continuum of antimicrobial stewardship in the fight against antimicrobial resistance

Antimicrobial activity of cell free supernatants from probiotics inhibits against pathogenic bacteria isolated from fresh boar semen

Rapid Diagnostic Tests and Their Effect on Antimicrobial Stewardship

S’pore scientists develop ‘nano-nets’ to trap, kill bacteria amid growing antibiotic resistance

Collateral sensitivity profiling in drug-resistant Escherichia coli identifies natural products suppressing cephalosporin resistance

The F-pilus biomechanical adaptability accelerates conjugative dissemination of antimicrobial resistance and biofilm formation

Evaluation of a new antiresistic strategy to manage antibiotic resistance

Repurposing bacteria to fight disease

Identifying key bottlenecks in the early stages of antibiotic R&D and exploring public and not-for-profit solutions

Call for urgency to deliver on global pledge for antibiotic incentives

An Evidence-Based Serious Game App for Public Education on Antibiotic Use and Antimicrobial Resistance: Protocol of a Randomized Controlled Trial

Prediction of ciprofloxacin resistance in hospitalized patients using machine learning

Allelic diversity uncovers protein domains contributing to the emergence of antimicrobial resistance

IHMA new partner AMR Insights

Cooperative antibiotic resistance facilitates horizontal gene transfer

A novel combination therapy for treating vancomycin-resistant bacterial infections

Why pull incentives are key to catalysing private investment into antibiotics

WHO releases priorities for research and development of age-appropriate antibiotics

Targeting NAD+ regeneration enhances antibiotic susceptibility of Streptococcus pneumoniae during invasive disease

The Looming Antimicrobial Resistance (AMR) Pandemic: Opportunities for Investors

Artificial Intelligence vs Antibiotic Resistance

FINAL deadline to apply for CARB-X funding

GARDP and the University of Liverpool plan to boost collaboration on AMR

Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans

ChatGPT and antimicrobial advice: the end of the consulting infection doctor?

SMART researchers develop novel combination bacterium- and host-targeted therapy for treating vancomycin-resistant bacterial infections

WHO 2023 data call is now open for antibacterials in the preclinical development pipeline

Antimicrobial Peptides and Cell-Penetrating Peptides: Non-Antibiotic Membrane-Targeting Strategies Against Bacterial Infections

28 February 2023

Innovate UK KTN Launches Phage Innovation Network

23 February 2023

Doherty researchers develop world-first AMR detection tool 

20 February 2023

Impact funds help fight dementia and antibiotic resistance

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed